February 8, 2021

Izzo NJ et al. Alzheimer’s Dement 2021;1–18.

Preclinical and clinical biomarker studies of CT1812:
A novel approach to Alzheimer’s disease modification

Izzo NJ et al. Alzheimer'sDement 2021-image

 

Download publication

You might also be interested by

Brochures

High Performance Technologies for Cytokine Measurement

November 8, 2021

Immune Monitoring

More info

Brochures

Cell Therapy

November 5, 2021

Histopathology

More info

Brochures

Oncology & Immuno-Oncology Expertise

November 5, 2021

Histopathology

More info